The Planet Wellness Organization’s (WHO) Professional Committee on Drug Dependence have proposed amending the classification of cannabis below international law.
According to reporting in the British Healthcare Journal, the WHO policy reversal “takes account of the developing proof for the health-related applications of the drug,” and marks the initially time that the agency has reviewed its stance on cannabis in almost 60 years.
The advised modifications, outlined in a letter by WHO Director-Basic Dr. Tedros Adhanom Ghebreyesus and reported on by NORML, get in touch with for cannabis to be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs. Schedule IV is the most restrictive classification below the treaty. Rather, the committee advises that entire-plant cannabis and THC be designated as Schedule I controlled substances below international law.
“The present [international] scheduling of cannabis is as strict as that for heroin,” the BMJ summarizes. “[T]he Committee believes that maintaining cannabis at that level of handle would severely restrict access to and investigation on prospective therapies derived from the plant.”
In a separate recommendation, the Committee reiterated its 2017 request that preparations containing “pure cannabidiol … and not far more than .two % of delta-9-tetrahydrocannabinol” no longer be scheduled inside the international drug conventions.
The Committee’s policy suggestions now await action from the 53 participating members states of the United Nation’s Commission on Narcotic Drugs. The Commission is anticipated to vote on the challenge in March.
In October, NORML delivered over 10,000 public comments to the US Meals and Drug Administration urging the agency to suggest that WHO reschedule cannabis internationally.